D

Derralynn Hughes

Royal Free London NHS Foundation Trust

ORCID: 0000-0003-4531-9173

693 papers and 18.6k citations.

PubIndex Score98Top 2%How it's scored

693Publications

18.6kTotal Citations

First senior author: 1995

Top publicationsby citations

Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

Dominique P. Germain, Raphael Schiffmann, Derralynn Hughes et al.|New England Journal of Medicine|2016

Cited by 555

Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study

Maarten Arends, Carla E. M. Hollak, Christoph Wanner et al.|Journal of the American Society of Nephrology|2016

Cited by 421

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

Marieke Biegstraaten, Carla E. M. Hollak, Reynir Arngrı́msson et al.|Orphanet Journal of Rare Diseases|2015

Cited by 345

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells

Alisdair McNeill, Anthony H.V. Schapira, Joana Magalhães et al.|Brain|2014

Cited by 321

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled study

Christian J. Hendriksz, Wolfgang Dummer, Barbara K. Burton et al.|Journal of Inherited Metabolic Disease|2014

Cited by 211

Indexing the rest of 693 publications…